ChatDiagram
clinical care · treatment pathway

Hypertension Follow-Up Pathway

A hypertension follow-up pathway makes the review cycle visible without reducing care to a single threshold or medication choice. The first decision distinguishes concerns that need urgent evaluation from routine follow-up. Routine care then brings measurements, history, risks, current medicines, and lifestyle factors into an individualized management discussion. Monitoring produces the next review point, and the result either continues the plan or returns to clinical reassessment. This makes the diagram useful for care-team education and appointment workflows. It is not a substitute for clinical judgment, local protocols, or emergency assessment.

種類 フローチャート規格 Sugiyama layered DAG + orthogonal routingエンジン schematex-flowchart更新日 2026/9/24
Hypertension Follow-Up
Drawing preview
依頼内容

“Create a clinician-led hypertension follow-up flowchart: review blood-pressure measurements and history, arrange urgent clinical evaluation if there is an urgent concern, otherwise review risks, medicines, and lifestyle factors; agree an individualized management plan; set monitoring; review follow-up readings; and either continue routine review when goals are met or reassess the plan with a clinician when they are not.”

次はこちらAdd a medication-adherence discussion before reassessment.Change the monitoring step to a home-reading log.
この図に含まれるもの

図の背後にある意思決定を読み解く。

01Urgent concern

A separate path avoids treating all readings as routine.

02Individualized plan

Management follows review of the person's risks and current treatment.

03Goal review

Follow-up readings determine whether reassessment is needed.

Use as a high-level service workflow for clinician-led follow-up, not as a diagnosis or treatment protocol.

フローチャートのテンプレートをすべて見る →

よくある質問

よくある質問

Why review measurements and history together?

A clinician considers readings in context rather than treating one value as a complete assessment.

Why include a monitoring loop?

Follow-up data helps determine whether a plan should continue or be reassessed.

Does this specify treatment?

No. It intentionally maps the review process without prescribing individualized treatment.